Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Poseida Therapeutics Snares $142M In Series C

by vcnewsdaily.com posted 3months ago 233 views
SAN DIEGO, CA, Clinical-stage biopharmaceutical company has raised $142 million in Series C.

In this article